(Q34446644)

2 August 2017

1 reference

title

Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms (English)

1 reference

chronic obstructive pulmonary disease

2 August 2017

0 references

author name string

Debigaré R

series ordinal

1

1 reference

2 August 2017

Côté CH

series ordinal

2

1 reference

2 August 2017

Maltais F

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

1 reference

2 August 2017

164

1 reference

2 August 2017

1712-1717

1 reference

2 August 2017

9

1 reference

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.

2 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Series introduction: the transcription factor NF-kappaB and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Effect of chronic hypoxia on muscle enzyme activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Branched-chain amino acids inhibit proteolysis in rat skeletal muscle: mechanisms involved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2104035

10.1164/AJRCCM.164.9.2104035

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference